Browsing Tag
Abcam
3 posts
How Shift Bioscience is using AI and cell reprogramming to target aging at its core
Discover how Shift Bioscience is redefining longevity science with AI and cell rejuvenation—now backed by top-tier leadership from UK healthcare and research.
Danaher wraps up $5.7bn acquisition of Abcam to bolster life sciences segment
Danaher Corporation (NYSE: DHR), a renowned global science and technology innovator, has announced the completion of its acquisition…
Danaher to acquire protein consumables supplier Abcam for $5.7bn
Danaher Corporation (NYSE: DHR), a global science and technology innovator, has announced a definitive agreement to acquire Abcam…